(Q38219796)

English

A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Mamoru Watanabe

8

object named as

Mamoru Watanabe

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

author name string

Kiyonori Kobayashi

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Fumihito Hirai

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Makoto Naganuma

3

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Kenji Watanabe

4

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Takafumi Ando

5

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Hiroshi Nakase

6

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Katsuyoshi Matsuoka

7

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

publication date

10 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Journal of Crohn's and Colitis

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1444-1453

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Ulcerative proctitis: a review of pharmacotherapy and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Endoscopic characteristics of the healing process of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Importance of mucosal healing in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Esophageal capsule endoscopy in patients with suspected esophageal disease: double blinded comparison with esophagogastroduodenoscopy and assessment of interobserver variability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Magnification endoscopy for diagnosis of nonerosive reflux disease: a proposal of diagnostic criteria and critical analysis of observer variability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Intraclass correlations: uses in assessing rater reliability

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.05.005

21 January 2018

Identifiers

10.1016/J.CROHNS.2014.05.005

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38219796&oldid=1994575953"